In-vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus
- PMID: 2019857
- DOI: 10.1080/1120009x.1991.11739056
In-vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus
Abstract
Blastoschizomyces capitatus represents an emerging fungal pathogen in acute leukemia patients. The susceptibility to amphotericin B, 5-fluorocytosine, ketoconazole and fluconazole of nine clinical isolates was evaluated. A specific medium (high resolution medium) was used for testing fluconazole. This agent and 5-fluorocytosine were at least four- to eight-fold more active than amphotericin B and ketoconazole against all isolates but one.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources